XORTX Therapeutics Inc. Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Accounts payable and accrued liabilities (Tables)

Accounts payable and accrued liabilities (Tables)

12 Months Ended

Dec. 31, 2022

Accounts payable and accrued liabilities

Schedule of accounts payable and accrued liabilities


		December 31,		December 31,
		2022		2021
		$		$
Trade payables		1,758,486		410,701
Accrued liabilities		202,259		290,298
Total		1,960,745		700,999